TY  - JOUR
AU  - Gomez-Bravo, Miguel
AU  - Prieto Castillo, Martin
AU  - Navasa, Miquel
AU  - Sanchez-Antolin, Gloria
AU  - Llado, Laura
AU  - Otero, Alejandra
AU  - Serrano, Trinidad
AU  - Jimenez Romero, Carlos
AU  - Garcia Gonzalez, Miguel
AU  - Valdivieso, Andres
AU  - Gonzalez-Dieguez, Maria Luisa
AU  - de la Mata, Manuel
AU  - Pons, Jose A
AU  - Salcedo, Magdalena
AU  - Rodrigo, Juan M
AU  - Cuervas-Mons, Valentin
AU  - Gonzalez Rodriguez, Antonio
AU  - Caralt, Mireia
AU  - Pardo, Fernando
AU  - Varo Perez, Evaristo
AU  - Crespo, Gonzalo
AU  - Rubin, Angel
AU  - Guilera, Magda
AU  - Aldea, Anna
AU  - Santoyo, Julio
PY  - 2022
DO  - 10.17235/reed.2022.8549/2021
SN  - 1130-0108
UR  - http://hdl.handle.net/10668/21725
T2  - Revista espanola de enfermedades digestivas
AB  - Reduction in calcineurin inhibitor levels is considered crucial to decrease the incidence of kidney dysfunction in liver transplant (LT) recipients. The aim of this study was to evaluate the safety and impact of everolimus plus reduced tacrolimus (EVR...
LA  - en
PB  - Sociedad Española de Patologia Digestiva
KW  - Everolimus
KW  - De novo liver transplant
KW  - Renal function
KW  - eGFR
KW  - KDIGO
KW  - Drug therapy, combination
KW  - Everolimus
KW  - Graft rejection
KW  - Graft survival
KW  - Humans
KW  - Immunosuppressive agents
KW  - Kidney
KW  - Liver transplantation
KW  - Mycophenolic acid
KW  - Prospective studies
KW  - Tacrolimus
TI  - Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.
TY  - research article
VL  - 114
ER  -